• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-20

  This 2024 ACS Biomaterials Science & Engineering study clarifies how nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Using a mucosal in vitro model and inhibitor profiling, it identifies energy-dependent uptake, with macropinocytosis and caveolae-mediated endocytosis as dominant contributors, while clathrin-mediated uptake appears partial and phagocytosis negligible under the tested conditions.

• HotStart 2X Green qPCR Master Mix for HCC

  2026-08-20

  HotStart 2X Green qPCR Master Mix supports SYBR Green qPCR workflows for gene expression analysis and nucleic acid quantification. Its antibody-mediated Taq polymerase hot-start inhibition helps limit pre-cycling nonspecific amplification, while assay controls and melt-curve analysis remain necessary for defensible HCC pathway measurements.

• Mianserin HCl: Applied Research Workflows

  2026-08-19

  Mianserin HCl combines noradrenergic activity with 5-HT2 receptor antagonism, making it useful for receptor signaling, antidepressant, and psychiatric disorder research. This guide translates its reported pharmacology, cyclodextrin complexation, and antipathogenic findings into controlled bench workflows with practical troubleshooting strategies.

• DAPT (GSI-IX) in Hepatobiliary Organoid Research

  2026-08-19

  DAPT (GSI-IX) provides a practical way to perturb γ-secretase-dependent Notch signaling in human hepatobiliary organoids while monitoring both lineage decisions and liver-specific function. This workflow connects a defined small-molecule intervention with the hiPSC organoid platform described in the reference study, supporting mechanistic, disease-modeling, and drug-development experiments.

• Localized BDNF Release in Early NMJ Assembly

  2026-08-18

  The reference study shows that muscle-derived BDNF is not released uniformly: it is trafficked to podosome-like structures, processed, and secreted locally to organize early acetylcholine receptor clusters at developing neuromuscular junctions. By combining live-cell imaging, targeted perturbations, and muscle-specific BDNF knockout mice, the work connects spatial signaling with the earliest stages of postsynaptic assembly.

• Perphenazine: Practical Research Workflows

  2026-08-18

  Perphenazine is a well-characterized dopamine D2 receptor antagonist for connecting receptor pharmacology with mitochondrial, neuronal, and macrophage assays. This guide translates its reported effects into practical workflows for mitochondria-mediated cell death induction, host-directed antibacterial studies, and mechanism-focused neuropharmacology research.

• PGF2α/PTGFR Controls Endometrial Breakdown via HIF-1α

  2026-08-17

  A 2024 study identifies PGF2α signaling through PTGFR as a major regulator of endometrial shedding and vascular permeability in a mouse menstrual-like model. Its combination of receptor antagonism, HIF-1α inhibition, vascular readouts, and promoter-binding analysis supports a mechanistic HIF-1α–PTGFR–VEGF axis while highlighting important limits on translation to human menstruation.

• 2-D08: Selective Protein Sumoylation Inhibition

  2026-08-17

  2-D08, also called 2’,3’,4’-trihydroxyflavone, is a small-molecule inhibitor of protein sumoylation that blocks SUMO transfer from UBC9 without blocking E1 activation or UBC9-SUMO thioester formation. Its reported use is limited to in vitro mechanistic studies, including topoisomerase I sumoylation inhibition in breast cancer cells.

• BHQ for SERCA and Calcium Signaling Research

  2026-08-16

  BHQ gives researchers a practical way to perturb SERCA-dependent calcium storage, from acute calcium imaging to hematopoietic stem cell mobilization assays. This guide connects reagent handling, pathway-resolved readouts, vascular applications, and troubleshooting without treating a mechanistic research tool as a clinical intervention.

• Phenothiazines, ROS, and Macrophage Antibacterial Activity

  2026-08-15

  The 2025 Frontiers in Immunology study shows that phenothiazines, including perphenazine, can strengthen macrophage antibacterial activity through coordinated increases in reactive oxygen species, lysosomal activity, and autophagy. Its host-directed framework provides a mechanistic basis for investigating phenothiazine scaffolds against intracellular Salmonella while highlighting important limits on translation beyond the tested models.

• IWP-2 Workflow for Wnt Pathway Studies

  2026-08-14

  IWP-2 is a potent Wnt production inhibitor for testing how Porcupine-dependent ligand secretion shapes cancer phenotypes, apoptosis, and cell morphology. This practical workflow connects pathway assays with high-content imaging, using the gastric cancer cell line MKN28 as a benchmark while highlighting critical solubility and interpretation controls.

• AL-8810: FP Receptor Antagonist Workflow

  2026-08-14

  AL-8810 enables receptor-level dissection of PGF2α responses in endometrial, vascular, and smooth-muscle models. This workflow connects competitive FP receptor blockade with ERK1/2, MMP-2, VEGF-A, permeability, and tissue-remodeling readouts while providing practical optimization guidance.

• TUDCA Workflows for ER Stress and Neuroprotection

  2026-08-13

  Tauroursodeoxycholic Acid (TUDCA) gives researchers a practical chemical-chaperone tool for separating ER stress, mitochondrial injury, inflammation, and apoptosis in cell-based models. This workflow translates ER stress findings from subarachnoid hemorrhage research into reproducible assay design for neurodegenerative, metabolic, and regenerative studies.

• Perphenazine: A Mechanism-to-Assay Research Guide

  2026-08-13

  Perphenazine is a dopamine D2 receptor antagonist with a distinctive multi-receptor and mitochondrial activity profile. This guide translates its neuropharmacology, host-directed antibacterial evidence, and cell-based assay considerations into a practical research framework.

• Dinaciclib (SCH727965) for Reliable Cell Assays

  2026-08-12

  This scenario-driven guide explains how Dinaciclib (SCH727965), SKU A8412, can support reproducible cell-cycle, viability, apoptosis, and boundary-oriented experiments. It connects product formulation and target potency with practical controls, interpretation strategies, and candid vendor-selection criteria.

8495 records 2/567 page Previous Next 12345 下5页 Last page